AI Helping Predict Drug Safety Risks Earlier in Development
One of the most devastating outcomes in pharmaceutical development is when a drug candidate, after years of research and millions of dollars in investment,...
AI Enabling Smarter Formulation Development in Pharma
In the pharmaceutical industry, the discovery of a potent new drug molecule is only half the battle. For that molecule to become a successful...
Advancing Real-World Evidence in Pharma through AI Processes
The traditional gold standard for pharmaceutical research has long been the Randomized Controlled Trial (RCT). These trials, conducted in highly controlled environments with carefully...
The Emerging Need for AI Governance in Pharma Sector
The pharmaceutical industry is currently experiencing a technological renaissance, with artificial intelligence (AI) being integrated into every facet of the business—from the initial spark...
FDA Approves Zanvastro as First Alexander Disease Treatment
The U.S. Food and Drug Administration has approved Zanvastro (zilganersen) injection for treating pediatric and adult patients with Alexander disease. The approval makes Zanvastro...
Eli Lilly Announces Acquisition of Merida Biosciences
Eli Lilly has entered into a definitive agreement to acquire Merida Biosciences. This USD 2.875B deal aims to expand the developer's immunology portfolio by...
FDA Approves Mimrylo for Rare Blood Disorder Treatment
The U.S. Food and Drug Administration (FDA) approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder in which...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...